INO Inovio Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 12, 2026
$1,16
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$0,5652tyg. minimum
$2,6852tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$96M
P/E (TTM)
-1.1
EPS (TTM)
$-1.04
Przychody (TTM)
$0
Twoje odznaki
Zakres 52 tyg.
$1–$3
Ocena Analityków
BUY
Cena Docelowa
$3
P/E
-1.1
ROE
-409.9%
Marża Zysku Netto
-130000.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
INO Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.16
Kapitalizacja Rynkowa (MRQ)
$96M
P/E (TTM)
-1.1
EPS (TTM)
$-1.04
Przychody (TTM)
$0
ROE (TTM)
-409.9%
Zakres 52 tyg.
$1–$3
INO Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 25 stycznia 2024 | 1-for-12 | Odwrotny |
| 6 czerwca 2014 | 1-for-4 | Odwrotny |
| 13 września 2004 | 1-for-4 | Odwrotny |
O Inovio Pharmaceuticals, Inc. - Common Stock Przegląd firmy z Wikipedii
Inovio Pharmaceuticals, Inc. – amerykańskie przedsiębiorstwo biotechnologiczne założone w 1983 roku, z siedzibą w Plymouth Meeting w Pensylwanii.
Działalność przedsiębiorstwa koncentruje się na odkrywaniu, opracowywaniu oraz komercjalizacji metod immunoterapii i szczepionek opartych na DNA.
Źródło: Wikipedia, CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealthcare
branżaBiotechnology
pracownicy112
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$65.3K2016-12-31 → 2025-12-31
EPS$-1.812016-12-31 → 2025-12-31
Wolny przepływ pieniężny$-89M2016-12-31 → 2025-12-31
Marża netto-130000.0%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | INO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -1.1średnia z 5 lat ≈-1.4 | ≈-1.4 | · | · | |
| P/S | 1224.9średnia z 5 lat ≈2020.9 | ≈2020.9 | 232.7 | Zawyżona wycena | |
| P/B (MRQ) | 21.9średnia z 5 lat ≈12.2 | ≈12.2 | 2.8 | Zawyżona wycena | |
| Cena / FCF (TTM) | -1.2średnia z 5 lat ≈-17.0 | ≈-17.0 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -1.2średnia z 5 lat ≈-17.1 | ≈-17.1 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 3.3średnia z 5 lat ≈12.7 | ≈12.7 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | INO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Operating Margin (Marża Operacyjna) | -132871.3%średnia z 5 lat ≈-44273.6% | ≈-44273.6% | -1300.3% | Słaby | |
| EBITDA Margin (Marża EBITDA) | -132871.3%średnia z 5 lat ≈-44273.6% | ≈-44273.6% | -1300.3% | Słaby | |
| Pretax Margin (Marża przed opodatkowaniem) | -130000.0%średnia z 5 lat ≈-43057.0% | ≈-43057.0% | -2475.3% | Słaby | |
| Net Profit Margin (Marża Zysku Netto) | -130000.0%średnia z 5 lat ≈-43066.1% | ≈-43066.1% | -2227.9% | Słaby | |
| ROA (TTM) | -114.6%średnia z 5 lat ≈-68.6% | ≈-68.6% | -45.0% | Słaby | |
| ROE (TTM) | -409.9%średnia z 5 lat ≈-153.0% | ≈-153.0% | -103.7% | Słaby | |
| ROIC | -360.3%średnia z 5 lat ≈-168.6% | ≈-168.6% | -93.3% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | INO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.0średnia z 5 lat ≈3.6 | ≈3.6 | 5.0 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 1.3średnia z 5 lat ≈3.3 | ≈3.3 | 3.3 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | INO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -70.0%średnia z 5 lat ≈33.3% | ≈33.3% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -81.5%średnia z 5 lat ≈-61.2% | ≈-61.2% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -61.2% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | INO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.0średnia z 5 lat ≈0.0 | ≈0.0 | 0.0 | Słaby | |
| Receivables Turnover (Rotacja należności) | 0.1średnia z 5 lat ≈0.8 | ≈0.8 | 5.9 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$583.42 | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
24.6%
Następny raport
Lis 09, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 10, 2026 | $-0.07 | $-0.22 | 68.0% |
| 31 marca 2026 | Maj 11, 2026 | $-0.28 | $-0.35 | 20.8% |
| 31 grudnia 2025 | $0.06 | $-0.36 | 116.6% | |
| 30 września 2025 | $-0.87 | $-0.43 | -103.6% | |
| 30 czerwca 2025 | $-0.61 | $-0.62 | 0.86% | |
| 31 marca 2025 | $-0.41 | $-0.75 | 45.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3K | $217.8K | $832.0K | $10M | $2M | $7M | $4M | $30M | $42M | $35M | $41M | $10M | |
| R&D Expense | $54M | $76M | $87M | $188M | $249M | $94M | $88M | $95M | $99M | $89M | $58M | $34M | |
| SG&A Expense | $33M | $37M | $48M | $90M | $54M | $37M | $27M | $29M | $28M | $24M | $18M | $16M | |
| Operating Expenses | $87M | $113M | $145M | $278M | $303M | $131M | $115M | $125M | $126M | $112M | $75M | $50M | |
| Operating Income | $-87M | $-112M | $-144M | $-268M | $-301M | $-124M | $-111M | $-94M | $-84M | $-76M | $-34M | $-39M | |
| Interest Expense | · | · | $1M | $1M | $2M | $9M | $8M | $0 | $25.9K | · | · | · | |
| Interest Income | $2M | $5M | $8M | $5M | $3M | $3M | $3M | $2M | $2M | · | · | · | |
| Other Non-op | $-3M | $-3M | $-5M | $-4M | $343.4K | $-704.9K | $496.2K | $-1M | $-197.5K | · | · | · | |
| Pretax Income | $-85M | $-107M | $-135M | $-278M | $-303M | $-163M | $-121M | $-95M | $-88M | $-74M | $-31M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-257.3K | $2M | $0 | $0 | $-2M | $0 | |
| Net Income | $-85M | $-107M | $-135M | $-280M | $-304M | $-166M | $-119M | $-97M | $-88M | $-74M | $-29M | $-36M | |
| EPS (Basic) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 | $-1.07 | $-1.21 | $-1.05 | $-1.08 | $-1.01 | $-0.43 | $-0.61 | |
| EPS (Diluted) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 | $-1.07 | $-1.21 | $-1.05 | $-1.09 | $-1.01 | $-0.44 | $-0.64 | |
| Shares (Basic) | 46,886,413 | 27,160,863 | 22,173,662 | 19,885,182 | 17,402,483 | 155,126,857 | 98,717,999 | 92,539,997 | 81,777,493 | 73,214,766 | 68,198,142 | 59,127,349 | |
| Shares (Diluted) | 46,886,413 | 27,160,863 | 22,173,662 | 19,885,182 | 17,402,483 | 155,126,857 | 98,717,999 | 92,539,997 | 81,918,022 | 73,214,766 | 68,365,265 | 59,408,252 | |
| EBITDA | $-87M | $-112M | $-144M | $-268M | $-301M | $-124M | $-111M | $-94M | $-84M | $-76M | $-34M | $-39M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $66M | $14M | $46M | $71M | $251M | $22M | $24M | $24M | $19M | $58M | $41M | |
| Short-term Investments | $14M | $28M | $131M | $207M | $330M | $161M | $67M | $58M | $104M | $86M | $105M | $53M | |
| Receivables | $450 | $1M | $2M | $2M | $5M | $19M | $700.1K | $3M | $6M | $16M | $7M | $3M | |
| Prepaid Expense | $3M | $4M | $5M | $50M | $39M | $40M | $2M | $1M | $3M | $2M | $917.3K | $798.0K | |
| Current Assets | $61M | $98M | $153M | $315M | $448M | $471M | $94M | $88M | $138M | $125M | $172M | $99M | |
| PP&E (Net) | $3M | $4M | $5M | $8M | $17M | $11M | $13M | $16M | $18M | $9M | $7M | $5M | |
| PP&E (Gross) | $20M | $20M | $26M | $29M | $36M | $27M | $26M | $26M | $25M | $14M | $11M | $7M | |
| Accum. Depreciation | $17M | $16M | $21M | $22M | $19M | $16M | $13M | $10M | $7M | $5M | $4M | $3M | |
| Goodwill | · | · | $0 | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $10M | $10M | |
| Intangibles | · | · | $0 | $2M | $3M | $3M | $4M | $5M | $6M | $8M | $4M | $5M | |
| Other Non-current Assets | $2M | $2M | $605.3K | $684.0K | $1M | $26M | $3M | $3M | $3M | $2M | $670.8K | $474.6K | |
| Total Assets | $74M | $113M | $171M | $349M | $496M | $540M | $144M | $131M | $187M | $174M | $214M | $132M | |
| Accounts Payable | · | · | · | $80M | $48M | $21M | $18M | $23M | $23M | $20M | $13M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $6M | $9M | $6M | $3M | $2M | |
| Current Liabilities | $44M | $35M | $43M | $97M | $66M | $42M | $32M | $35M | $35M | $44M | $31M | $14M | |
| Capital Leases | $7M | $9M | $11M | $13M | $15M | $18M | $20M | · | · | · | · | · | |
| Deferred Tax | · | · | $0 | $32.0K | $32.0K | $32.0K | $32.0K | $24.8K | $24.8K | $174.8K | $175.6K | $504.0K | |
| Other Non-current Liabilities | · | · | · | $0 | $14.8K | $57.7K | $36.9K | $87.3K | $0 | · | · | · | |
| Total Liabilities | $50M | $45M | $54M | $126M | $96M | $79M | $139M | $44M | $45M | $50M | $38M | $20M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Common Stock | $69.0K | $36.1K | $22.8K | $21.1K | $217.4K | $186.9K | $101.4K | $97.2K | $90.4K | $74.1K | $72.2K | $60.7K | |
| Paid-in Capital | $1.84B | $1.80B | $1.74B | $1.71B | $1.61B | $1.37B | $743M | $708M | $666M | $557M | $534M | $443M | |
| Retained Earnings | $-1.82B | $-1.73B | $-1.62B | $-1.49B | $-1.21B | $-906M | $-740M | $-620M | $-523M | $-435M | $-361M | $-332M | |
| AOCI | $-638.0K | $-675.7K | $-662.6K | $-698.7K | $-282.2K | $-256.1K | $472.6K | $-528.9K | $-117.0K | $1M | $3M | $-251.4K | |
| Stockholders' Equity | $24M | $69M | $117M | $222M | $400M | $461M | $3M | $87M | $142M | $123M | $176M | $111M | |
| Liabilities + Equity | $74M | $113M | $171M | $349M | $496M | $540M | $144M | $131M | $187M | $174M | $214M | $132M | |
| Shares Outstanding | 68,996,647 | 36,099,991 | 22,793,075 | 21,090,938 | 217,382,887 | 186,851,493 | 101,361,034 | 97,225,810 | 90,357,644 | 74,062,370 | 72,217,965 | 60,741,082 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $7M | $11M | $23M | $26M | $16M | $11M | $11M | $13M | $10M | $6M | $5M | |
| Deferred Tax | · | $0 | $-32.0K | $0 | $0 | $0 | $-263.0K | $0 | $0 | $0 | $-2M | $27.0K | |
| Amort. of Intangibles | · | $0 | $145.4K | $496.5K | $520.4K | $547.1K | $1M | $1M | $2M | $1M | $870.2K | $942.7K | |
| Operating Cash Flow | $-89M | $-104M | $-124M | $-216M | $-216M | $-178M | $-98M | $-74M | $-63M | $-63M | $-12M | $-30M | |
| CapEx | $285.7K | $487.8K | $320.9K | $969.2K | $1M | $2M | $987.9K | $2M | $10M | $3M | $3M | $1M | |
| Investing Cash Flow | $14M | $104M | $87M | $110M | $-175M | $-59M | $-9M | $42M | $-28M | $16M | $-55M | $-36M | |
| Debt Issued | · | · | · | · | $0 | $0 | $97M | $0 | $0 | · | · | · | |
| Net Debt Issued | · | · | · | · | $0 | $0 | $97M | · | · | · | · | · | |
| Stock Issued | $35M | $36M | $5M | $83M | $209M | $454M | $9M | $29M | $94M | $6M | $82M | $59M | |
| Net Stock Activity | $35M | $36M | $5M | $83M | $209M | $454M | $9M | $29M | $94M | $6M | $82M | $59M | |
| Financing Cash Flow | $53M | $51M | $5M | $82M | $211M | $465M | $105M | $31M | $96M | $8M | $84M | $72M | |
| Net Change in Cash | $-22M | $52M | $-32M | $-25M | $-180M | $229M | $-1M | $-92.9K | $5M | $-38M | $17M | $7M | |
| Free Cash Flow | $-89M | $-105M | $-125M | $-217M | $-217M | $-179M | $-99M | $-76M | $-74M | $-65M | $-15M | $-31M | |
| Levered FCF | · | · | $-126M | $-218M | $-219M | $-188M | $-107M | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -132871.3% | -51616.9% | -17300.3% | -2607.3% | -16972.3% | -1674.2% | -2702.1% | -308.7% | -198.1% | -215.6% | -84.5% | -377.7% | |
| Net Margin | -130000.0% | -49254.3% | -16239.9% | -2726.7% | -17109.9% | -2245.4% | -2902.8% | -318.1% | -208.9% | -208.5% | -71.9% | -345.4% | |
| Pretax Margin | -130000.0% | -49254.3% | -16239.9% | -2705.6% | -17085.4% | -2197.9% | -2938.0% | -311.0% | -208.9% | -208.5% | -76.9% | · | |
| EBITDA Margin | -132871.3% | -51616.9% | -17300.3% | -2607.3% | -16972.3% | -1674.2% | -2702.1% | -308.7% | -198.1% | -215.6% | -84.5% | -377.7% | |
| ROA | -90.6% | -75.5% | -52.0% | -66.3% | -58.6% | -48.7% | -86.8% | -60.9% | -48.9% | -38.0% | -16.9% | -32.8% | |
| ROE | -322.8% | -151.0% | -105.8% | -114.4% | -71.2% | -71.6% | -264.2% | -84.6% | -66.4% | -49.3% | -20.3% | -44.1% | |
| ROIC | -360.3% | -164.1% | -122.7% | -120.3% | -75.4% | -26.9% | -3226.5% | -110.7% | -58.7% | -61.8% | -18.2% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 2.8 | 3.6 | 3.3 | 6.8 | 11.3 | 2.9 | 2.5 | 3.9 | 2.8 | 5.5 | 7.1 | |
| Quick Ratio | 1.3 | 2.7 | 3.4 | 2.6 | 6.2 | 10.3 | 2.8 | 2.4 | 3.8 | 2.8 | 5.4 | 6.9 | |
| Interest Coverage | · | · | -117.7 | -213.4 | -155.6 | -14.3 | -14.0 | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | |
| Receivables Turnover | 0.1 | 0.1 | · | 2.9 | 0.1 | 0.8 | 2.0 | 6.5 | 3.9 | 3.1 | 8.0 | 3.4 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $1.90 | $5.15 | $0.88 | $1.84 | $2.47 | $0.03 | $0.89 | $1.58 | $1.66 | $2.43 | $1.83 | |
| Revenue / Share | $0.00 | $0.01 | $0.04 | $0.04 | $0.01 | · | $0.04 | $0.33 | $0.52 | $0.48 | $0.59 | $0.18 | |
| Cash Flow / Share | $-1.89 | $-3.83 | $-5.61 | $-0.91 | $-1.03 | · | $-0.99 | $-0.79 | $-0.77 | $-0.85 | $-0.18 | $-0.50 | |
| Cash / Share | $0.64 | $1.82 | $0.63 | $0.18 | $0.33 | $1.34 | $0.22 | $0.24 | $0.26 | $0.26 | $0.80 | $0.67 | |
| EPS (TTM) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 | $-1.07 | $-1.21 | $-1.05 | $-1.09 | $-1.01 | $-0.44 | $-0.64 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -70.0% | -73.8% | -91.9% | 478.2% | -76.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -81.5% | -50.3% | -51.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -61.2% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65.3K | $217.8K | $832.0K | $10M | $2M | $7M | $4M | $30M | $42M | $35M | $41M | $10M | |
| Net Income TTM | $-85M | $-107M | $-135M | $-280M | $-304M | $-166M | $-119M | $-97M | $-88M | $-74M | $-29M | $-36M | |
| Market Cap | $120M | $66M | $139M | $4.74B | $13.02B | $19.84B | $4.01B | $4.67B | $4.48B | $6.17B | $5.82B | $6.69B | |
| P/E | -1.0 | -0.5 | -1.0 | -1.3 | -3.4 | -99.3 | -32.7 | -45.7 | -45.5 | -82.5 | -183.3 | -172.1 | |
| P/S | 1837.3 | 303.4 | 167.7 | 461.7 | 7334.5 | 2677.5 | 976.2 | 153.1 | 106.1 | 174.4 | 143.5 | 639.9 | |
| P/B | 5.0 | 1.0 | 1.2 | 21.3 | 32.6 | 43.0 | 1168.5 | 53.7 | 31.4 | 50.0 | 33.1 | 60.2 | |
| P / Tangible Book | 5.0 | 1.0 | 1.2 | 22.6 | 33.7 | 44.3 | · | · | · | · | · | · | |
| P / Cash Flow | -1.4 | -0.6 | -1.1 | -21.9 | -60.3 | -111.5 | -41.0 | -63.5 | -70.8 | -98.6 | -468.2 | -224.4 | |
| P / FCF | -1.4 | -0.6 | -1.1 | -21.8 | -60.0 | -110.5 | -40.6 | -61.7 | -60.9 | -94.5 | -382.6 | -214.4 | |
| Earnings Yield | -104.0% | -215.9% | -99.5% | -75.2% | -29.1% | -1.0% | -3.1% | -2.2% | -2.2% | -1.2% | -0.55% | -0.58% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $65.3K | $117.0K | $0 | $100.8K | $0 | $388.4K | $226.0K | $114.9K | $9M | $784.4K | $199.1K | |
| R&D Expense | $11M | $14M | $10M | $13M | $15M | $16M | $13M | $19M | $23M | $21M | $16M | $24M | $30M | $33M | $56M | $56M | |
| SG&A Expense | $8M | $8M | $7M | $8M | $9M | $9M | $8M | $9M | $10M | $11M | $10M | $14M | $14M | $12M | $48M | $16M | |
| Operating Expenses | $19M | $22M | $17M | $21M | $23M | $25M | $20M | $27M | $33M | $31M | $36M | $37M | $44M | $45M | $105M | $72M | |
| Operating Income | $-19M | $-22M | $-17M | $-21M | $-23M | $-25M | $-20M | $-27M | $-33M | $-31M | $-36M | $-37M | $-44M | $-36M | $-104M | $-72M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $177.8K | $313.5K | $313.5K | $313.5K | $313.5K | $313.5K | $313.5K | |
| Interest Income | $363.8K | $439.6K | $449.3K | $552.1K | $610.6K | $808.1K | $852.6K | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $857.7K | $669.8K | |
| Other Non-op | $-2M | $-285.5K | $88 | $-2M | $-703.2K | $-482 | $-2M | $-579.8K | $7.6K | $-682.2K | $2.9K | $-1M | $-2M | $-940.8K | $-3.0K | $-153.5K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-34M | $-36M | $-41M | $-38M | $-108M | $-77M | |
| Net Income | $-6M | $-20M | $4M | $-45M | $-24M | $-20M | $-19M | $-25M | $-32M | $-30M | $-34M | $-36M | $-41M | $-38M | $-108M | $-79M | |
| EPS (Basic) | $-0.07 | $-0.28 | $0.18 | $-0.87 | $-0.61 | $-0.51 | $-0.56 | $-0.89 | $-1.19 | $-1.31 | $-1.52 | $-1.61 | $-1.89 | $-0.15 | $-0.46 | $-0.36 | |
| EPS (Diluted) | $-0.07 | $-0.28 | $0.18 | $-0.87 | $-0.61 | $-0.51 | $-0.56 | $-0.89 | $-1.19 | $-1.31 | $-1.52 | $-1.61 | $-1.89 | $-0.15 | $-0.46 | $-0.36 | |
| Shares (Basic) | 81,619,113 | 69,101,910 | · | 52,168,694 | 38,830,053 | 38,613,653 | · | 28,140,497 | 27,197,802 | 23,291,512 | 22,385,229 | 22,029,486 | 21,536,476 | 249,351,023 | 235,278,276 | 218,940,693 | |
| Shares (Diluted) | 81,619,113 | 69,101,910 | · | 52,168,694 | 38,830,053 | 38,613,653 | · | 28,140,497 | 27,197,802 | 23,291,512 | 22,385,229 | 22,029,486 | 21,536,476 | 249,351,023 | 235,278,276 | 218,940,693 | |
| EBITDA | $-19M | $-22M | · | $-21M | $-23M | $-25M | · | $-27M | $-33M | $-31M | $-36M | $-37M | $-44M | $-36M | $-104M | $-72M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $26M | $44M | $37M | $24M | $40M | $66M | $22M | $34M | $20M | $19M | $53M | $28M | $22M | $41M | $59M | |
| Short-term Investments | $5M | $11M | $14M | $14M | $23M | $28M | $28M | $63M | $76M | $86M | $149M | $142M | $196M | $260M | $307M | $301M | |
| Receivables | · | · | $450 | $978.6K | $840.3K | $1M | $1M | $2M | $2M | $3M | · | · | $73.3K | $2M | $4M | $4M | |
| Prepaid Expense | $3M | $2M | $3M | $3M | $4M | $2M | $4M | $5M | $5M | $4M | $5M | $3M | $5M | $58M | $56M | $32M | |
| Current Assets | $40M | $39M | $61M | $55M | $53M | $72M | $98M | $91M | $118M | $112M | $175M | $203M | $234M | $350M | $416M | $400M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $16M | $16M | $17M | |
| PP&E (Gross) | · | · | $20M | · | · | · | $20M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $16M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $0 | $11M | $11M | $11M | $11M | $11M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $566.4K | $585.9K | $605.3K | $605.3K | $666.9K | $652.5K | $702.0K | $770.1K | $1M | |
| Total Assets | $49M | $50M | $74M | $69M | $68M | $87M | $113M | $107M | $134M | $129M | $193M | $233M | $267M | $392M | $459M | $446M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $74M | $105M | $38M | |
| Current Liabilities | $40M | $38M | $44M | $70M | $32M | $27M | $35M | $23M | $26M | $23M | $44M | $52M | $55M | $95M | $131M | $59M | |
| Capital Leases | $5M | $6M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | $15M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | $710.3K | $0 | $0 | |
| Total Liabilities | $45M | $44M | $50M | $77M | $40M | $36M | $45M | $34M | $37M | $35M | $55M | $64M | $67M | $125M | $162M | $90M | |
| Common Stock | $82.3K | $69.8K | $69.0K | $53.6K | $36.7K | $36.7K | $36.1K | $26.1K | $26.0K | $23.4K | $269.7K | $268.1K | $262.7K | $249.5K | $247.5K | $226.5K | |
| Paid-in Capital | $1.85B | $1.84B | $1.84B | $1.81B | $1.80B | $1.80B | $1.80B | $1.78B | $1.78B | $1.75B | $1.74B | $1.73B | $1.73B | $1.70B | $1.69B | $1.64B | |
| Retained Earnings | $-1.84B | $-1.83B | $-1.82B | $-1.82B | $-1.77B | $-1.75B | $-1.73B | $-1.71B | $-1.69B | $-1.65B | $-1.60B | $-1.56B | $-1.53B | $-1.43B | $-1.40B | $-1.29B | |
| AOCI | $-280.0K | $-636.1K | $-638.0K | $-647.4K | $-661.7K | $-661.3K | $-675.7K | $-623.5K | $-689.5K | $-676.2K | $-751.1K | $-691.3K | $-582.8K | $-885.2K | $-649.7K | $-457.9K | |
| Stockholders' Equity | $4M | $6M | $24M | $-8M | $29M | $51M | $69M | $74M | $97M | $94M | $138M | $169M | $199M | $267M | $298M | $355M | |
| Liabilities + Equity | $49M | $50M | $74M | $69M | $68M | $87M | $113M | $107M | $134M | $129M | $193M | $233M | $267M | $392M | $459M | $446M | |
| Shares Outstanding | 82,341,945 | 69,773,237 | 68,996,647 | 53,571,675 | 36,718,527 | 36,674,355 | 36,099,991 | 26,052,452 | 25,963,544 | 23,371,253 | 269,731,481 | 268,073,202 | 262,739,126 | 249,485,264 | 247,504,547 | 226,510,720 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $768.4K | $698.7K | $764.6K | $757.1K | $834.8K | $1M | $1M | $1M | $2M | $3M | $2M | $3M | $4M | $3M | $8M | $8M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $63.3K | $82.1K | $120.0K | $131.0K | $126.8K | |
| Operating Cash Flow | $-18M | $-22M | $-19M | $-22M | $-21M | $-27M | $-20M | $-27M | $-28M | $-29M | $-29M | $-32M | $-37M | $-67M | $-51M | $-62M | |
| CapEx | $0 | $0 | $127.4K | $68.0K | $30.9K | $59.4K | $0 | $0 | $452.3K | $35.6K | $0 | $23.9K | $297.0K | $86.8K | $717.2K | $0 | |
| Investing Cash Flow | $6M | $3M | $-58.2K | $9M | $5M | $-51.8K | $35M | $14M | $10M | $45M | $-5M | $54M | $19M | $45M | $-10M | $21M | |
| Stock Issued | $3M | $1M | $27M | $7M | $0 | $1M | $13M | $667.1K | $17M | $5M | $708.3K | $3M | $0 | $4M | $43M | $29M | |
| Net Stock Activity | · | $1M | · | · | · | $1M | · | · | · | $5M | · | · | $0 | · | · | $29M | |
| Financing Cash Flow | $17M | $953.8K | $27M | $25M | $-34.8K | $1M | $29M | $660.6K | $33M | $-11M | $698.6K | $3M | $-424.7K | $4M | $43M | $28M | |
| Net Change in Cash | $5M | $-18M | $8M | $12M | $-16M | $-26M | $44M | $-13M | $15M | $5M | $-34M | $24M | $-18M | $-19M | $-18M | $-12M | |
| Free Cash Flow | · | $-22M | · | · | · | $-27M | · | · | · | $-29M | · | · | $-37M | · | · | $-62M |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -38337.0% | · | · | -32945.9% | · | -9152.6% | -16392.0% | -38238.2% | -390.6% | -13276.1% | -36033.3% | |
| Net Margin | · | · | · | · | · | -30140.5% | · | · | -31993.3% | · | -8734.8% | -15725.3% | -35364.8% | -412.8% | -13832.0% | -39720.8% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -8734.8% | -15725.3% | -35364.8% | -412.8% | -13832.0% | -38633.1% | |
| EBITDA Margin | · | · | · | · | · | -38337.0% | · | · | -32945.9% | · | -9152.6% | -16392.0% | -38238.2% | -390.6% | -13276.1% | -36033.3% | |
| ROA | -10.2% | -28.7% | · | -51.6% | -23.3% | -18.2% | · | -16.8% | -17.6% | -15.4% | -11.6% | -10.3% | -11.4% | -8.2% | -20.6% | -14.4% | |
| ROE | -36.5% | -68.7% | · | -138.2% | -37.5% | -27.0% | · | -23.8% | -24.2% | -20.8% | -16.8% | -15.2% | -14.7% | -10.5% | -26.9% | -16.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.0 | · | 0.8 | 1.7 | 2.6 | · | 3.9 | 4.5 | 4.8 | 4.0 | 3.9 | 4.2 | 3.7 | 3.2 | 6.7 | |
| Quick Ratio | 0.9 | 1.0 | · | 0.7 | 1.5 | 2.5 | · | 3.7 | 4.2 | 4.6 | 3.8 | 3.8 | 4.1 | 3.0 | 2.7 | 6.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -177.0 | -113.4 | -118.2 | -140.2 | -114.1 | -332.2 | -228.8 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.1 | 2.5 | 0.1 | 0.0 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.05 | $0.09 | · | $-0.14 | $0.78 | $1.40 | · | $2.82 | $3.73 | $4.04 | $0.51 | $0.63 | $0.76 | $1.07 | $1.20 | $1.57 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.70 | · | · | · | $-1.23 | · | · | $-0.14 | · | · | $-0.28 | |
| Cash / Share | $0.38 | $0.38 | · | $0.68 | $0.66 | $1.09 | · | $0.83 | $1.32 | $0.84 | $0.07 | $0.20 | $0.11 | $0.09 | $0.17 | $0.26 | |
| EPS (TTM) | $-1.04 | $-1.58 | · | $-2.55 | $-2.57 | $-3.15 | · | · | · | · | · | · | · | $-17.47 | $-17.61 | $-17.54 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $182.3K | $182.3K | $283.1K | · | · | · | · | · | · | · | $11M | $2M | $2M | |
| Net Income TTM | $-67M | $-85M | · | $-108M | $-88M | $-96M | · | · | · | · | · | · | · | $-332M | $-355M | $-328M | |
| Market Cap | $91M | $121M | · | $125M | $75M | $60M | · | $151M | $210M | $324M | $1.26B | $1.45B | $2.59B | $5.18B | $5.14B | $9.76B | |
| P/E | -1.1 | -1.1 | · | -0.9 | -0.8 | -0.5 | · | · | · | · | · | · | · | -1.2 | -1.2 | -2.5 | |
| P/S | · | · | · | 687.5 | 410.8 | 211.2 | · | · | · | · | · | · | · | 471.8 | 2430.2 | 6088.5 | |
| P/B | 20.7 | 20.0 | · | -16.2 | 2.6 | 1.2 | · | 2.0 | 2.2 | 3.4 | 9.1 | 8.5 | 13.0 | 19.4 | 17.3 | 27.5 | |
| P / Tangible Book | 20.7 | 20.0 | · | · | 2.6 | 1.2 | · | 2.0 | 2.2 | 3.4 | 9.1 | 9.1 | 13.9 | 20.4 | 18.0 | 28.5 | |
| P / Cash Flow | · | -5.6 | · | · | · | -2.2 | · | · | · | -11.3 | · | · | -70.5 | · | · | -157.7 | |
| Earnings Yield | -94.5% | -90.8% | · | -109.0% | -126.0% | -193.2% | · | · | · | · | · | · | · | -84.2% | -84.8% | -40.7% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $65.3K | $217.8K | $832.0K | $10M | $2M |
| Marża Operacyjna % | -132871.3% | -51616.9% | -17300.3% | -2607.3% | -16972.3% |
| Zysk netto | $-85M | $-107M | $-135M | $-280M | $-304M |
| Rozwodniony EPS | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-17.45 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.4 | 2.8 | 3.6 | 3.3 | 6.8 |
| Wskaźnik Szybkości | 1.3 | 2.7 | 3.4 | 2.6 | 6.2 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-89M | $-105M | $-125M | $-217M | $-217M |
Właściciele instytucjonalni (13F) 115 emitentów · $44.9M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
115
Wartość posiadanych akcji
$44.9M
Nowe pozycje
22
Zamknięte pozycje
15
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 22 (+3 vs poprzedni kw.) | 15 (+2 vs poprzedni kw.) | 33 (+11 vs poprzedni kw.) | 16 (-10 vs poprzedni kw.) | -1.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $9 300 277 | 8 454 797 | 20,70% | Akcje |
| JANUS HENDERSON GROUP PLC | $5 773 168 | 3 308 406 | 12,85% | Akcje |
| VANGUARD GROUP INC | $5 769 110 | 3 315 580 | 12,84% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 015 618 | 3 650 562 | 8,94% | Akcje |
| Boxer Capital Management, LLC | $3 129 493 | 2 844 994 | 6,96% | Akcje |
| ADAR1 Capital Management, LLC | $2 358 301 | 2 143 910 | 5,25% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 672 440 | 1 520 400 | 3,72% | Opcja kupna |
| D. E. Shaw & Co., Inc. | $1 486 822 | 1 351 656 | 3,31% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 363 756 | 1 239 778 | 3,03% | Akcje |
| Eversept Partners, LP | $1 138 896 | 1 035 360 | 2,53% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $883 749 | 802 751 | 1,97% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $875 718 | 796 107 | 1,95% | Akcje |
| BlackRock, Inc. | $856 963 | 779 057 | 1,91% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $528 846 | 480 769 | 1,18% | Akcje |
| Caption Management, LLC | $526 845 | 478 950 | 1,17% | Akcje |
| Caption Management, LLC | $440 000 | 400 000 | 0,98% | Opcja kupna |
| RENAISSANCE TECHNOLOGIES LLC | $397 473 | 361 339 | 0,88% | Akcje |
| STATE STREET CORP | $370 271 | 336 610 | 0,82% | Akcje |
| CITADEL ADVISORS LLC | $351 450 | 319 500 | 0,78% | Opcja kupna |
| TUDOR INVESTMENT CORP ET AL | $330 000 | 300 000 | 0,73% | Opcja kupna |
| DIADEMA PARTNERS LP | $302 720 | 275 200 | 0,67% | Opcja kupna |
| UBS Group AG | $288 552 | 262 320 | 0,64% | Akcje |
| Quadrature Capital Ltd | $284 821 | 258 928 | 0,63% | Akcje |
| CITADEL ADVISORS LLC | $265 952 | 241 775 | 0,59% | Akcje |
| NORTHERN TRUST CORP | $191 833 | 174 394 | 0,43% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $190 300 | 173 000 | 0,42% | Akcje |
| NOMURA HOLDINGS INC | $165 000 | 150 000 | 0,37% | Akcje |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $147 012 | 133 648 | 0,33% | Akcje |
| GMT Capital Corp | $138 731 | 126 119 | 0,31% | Akcje |
| JANE STREET GROUP, LLC | $136 977 | 124 525 | 0,30% | Akcje |
| TWO SIGMA ADVISERS, LP | $128 240 | 73 701 | 0,29% | Akcje |
| XTX Topco Ltd | $116 416 | 105 833 | 0,26% | Akcje |
| GOLDMAN SACHS GROUP INC | $103 092 | 93 720 | 0,23% | Akcje |
| CITADEL ADVISORS LLC | $92 620 | 84 200 | 0,21% | Opcja sprzedaży |
| Invesco Ltd. | $88 372 | 80 338 | 0,20% | Akcje |
| Green Alpha Advisors, LLC | $74 861 | 68 055 | 0,17% | Akcje |
| JANE STREET GROUP, LLC | $71 940 | 65 400 | 0,16% | Opcja kupna |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $63 690 | 57 900 | 0,14% | Opcja sprzedaży |
| MORGAN STANLEY | $55 283 | 50 256 | 0,12% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $46 515 | 42 286 | 0,10% | Akcje |
| Squarepoint Ops LLC | $40 030 | 36 391 | 0,09% | Akcje |
| Engineers Gate Manager LP | $37 060 | 33 691 | 0,08% | Akcje |
| Vanguard Global Advisers, LLC | $33 259 | 30 235 | 0,07% | Akcje |
| Headlands Technologies LLC | $32 878 | 29 889 | 0,07% | Akcje |
| ZACKS INVESTMENT MANAGEMENT | $29 079 | 26 435 | 0,06% | Akcje |
| Persistent Asset Partners Ltd | $22 160 | 701 | 0,05% | Opcja kupna |
| Prime Capital Investment Advisors, LLC | $18 839 | 17 126 | 0,04% | Akcje |
| LPL Financial LLC | $18 826 | 17 114 | 0,04% | Akcje |
| StoneX Group Inc. | $18 077 | 14 252 | 0,04% | Akcje |
| TWO SIGMA SECURITIES, LLC | $17 554 | 15 958 | 0,04% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Dr. J. Joseph Kim | 10 czerwca 2009 | · | Pierwotne zgłoszenie | · | SEC |
| Simon Benito, Tee Khiang Ng and Morton Collins, Voting Trustees Under Voting Trust Agreement Dated June 1, 2009 among the Issuer, the Voting Trustees and the Stockholders listed therein. | 10 czerwca 2009 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 42 insiderów · 12 dyrektorzy generalni · 24 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacqueline Elizabeth Shea | Chief Executive Officer | 20 maja 2026 A | 111 021 | 0 | 0 | $0 |
| Jong Joseph Kim | Chief Executive Officer | 11 marca 2022 M | 1 422 627 | 0 | 0 | $0 |
| Niranjan Sardesai | Chief Operating Officer | 10 marca 2018 M | 123 486 | 0 | 0 | $0 |
| Michael John Sumner | Chief Medical Officer | 20 maja 2026 A | 42 038 | 0 | 0 | $0 |
| Laurent Humeau | Chief Scientific Officer | 20 maja 2026 A | 46 823 | 0 | 0 | $0 |
| Mark Bagarazzi | Chief Medical Officer | 5 marca 2019 M | 100 672 | 0 | 0 | $0 |
| Kevin Rassas | Sr. VP Business Development | 16 listopada 2009 M | 726 088 | 0 | 0 | $0 |
| Cheryl Jo White | Chief Medical Officer | 29 czerwca 2009 M | · | 0 | 0 | $0 |
| Dietmar P Rabussay | V.P. Research & Development | 8 marca 2007 A | 17 386 | 0 | 0 | $0 |
| Robert S Goodenew | V.P. Corporate Development | 20 grudnia 2006 M | · | 0 | 0 | $0 |
| George F. Mchugh III | Vice President, Operations | 8 marca 2006 A | 1 | 0 | 0 | $0 |
| Brook G Riggins | V.P. Finance & Corp. Comm. | 7 listopada 2003 A | · | 0 | 0 | $0 |
| Ann Calby Miller | Dyrektor | 20 maja 2026 A | 9 877 | 0 | 0 | $0 |
| Roger D Dansey | Dyrektor | 20 maja 2026 A | 8 916 | 0 | 0 | $0 |
| David B. Weiner | Dyrektor | 20 maja 2026 A | 87 592 | 0 | 0 | $0 |
| Jay Shepard | Dyrektor | 20 maja 2026 A | 9 209 | 0 | 0 | $0 |
| Wendy L Yarno | Dyrektor | 20 maja 2026 A | 10 512 | 0 | 0 | $0 |
| Angel Cabrera | Dyrektor | 8 maja 2020 M | 75 602 | 0 | 0 | $0 |
| Morton Collins | Dyrektor | 11 maja 2019 M | 168 130 | 0 | 0 | $0 |
| Avtar S Dhillon | Dyrektor | 6 grudnia 2018 M | 106 002 | 0 | 0 | $0 |
| Adel Mahmoud | Dyrektor | 12 maja 2018 M | 22 669 | 0 | 0 | $0 |
| George Bickerstaff | Dyrektor | 21 marca 2018 M | 4 090 | 0 | 0 | $0 |
| Nancy Wysenski | Dyrektor | 13 maja 2016 A | 5 000 | 0 | 0 | $0 |
| Keith H Wells | Dyrektor | 13 maja 2011 A | · | 0 | 0 | $0 |
| David J Williams | Dyrektor | 16 czerwca 2010 A | · | 0 | 0 | $0 |
| Chin Cheong Chong | Dyrektor | 9 grudnia 2008 A | · | 0 | 0 | $0 |
| James L Heppell | Dyrektor | 14 sierpnia 2008 A | 2 | 0 | 0 | $0 |
| Stephen Rietiker | Dyrektor | 2 maja 2008 A | · | 0 | 0 | $0 |
| Robert William Rieder | Dyrektor | 2 maja 2008 A | · | 0 | 0 | $0 |
| Riaz Amirali Bandali | Dyrektor | 2 maja 2008 A | 2 | 0 | 0 | $0 |
| Tazdin Esmail | Dyrektor | 2 maja 2008 A | 2 | 0 | 0 | $0 |
| Felix Theeuwes | Dyrektor | 7 czerwca 2006 A | 2 | 0 | 0 | $0 |
| Eugene A Larson | Dyrektor | 13 maja 2005 A | 3 | 0 | 0 | $0 |
| Gordon Politeski | Dyrektor | 8 sierpnia 2003 A | · | 0 | 0 | $0 |
| MARXE AUSTIN W & GREENHOUSE DAVID M | Posiadacz 10% | 3 grudnia 2012 S | 3 919 706 | 0 | 0 | $0 |
| Lota S. Zoth | · | 20 maja 2026 A | 8 726 | 0 | 0 | $0 |
| Simon X Benito | · | 20 maja 2026 A | 12 191 | 0 | 0 | $0 |
| Peter Kies | · | 20 maja 2026 A | 42 854 | 0 | 0 | $0 |
| Tee Khiang Ng | · | 30 września 2009 A | · | 0 | 0 | $0 |
| Punit Dhillon | · | 30 września 2009 A | · | 0 | 0 | $0 |
| Michael Fons | · | 30 września 2009 A | · | 0 | 0 | $0 |
| Beng Lee Gan | · | 2 maja 2008 A | · | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 4 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 94 431 SH | 2 października 2026 | Dziennie |
| IWC · iShares Trust | 0,02% | 278 295 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 963 325 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 600 092 SH | 19 sierpnia 2026 | Dziennie |
INO Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 8 analityków
KUP
Średni cel
$3.00
+158,6%
2 25,0%
Mocne kupno
4 50,0%
Kup
2 25,0%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
3 analityków · 2026-09-29Średnia cel $3.17 +173,0%
← Poniżej wszystkich celów
Aktualna cena $1.16
Niski$2.50
Średnia$3.17
Wysoki$4.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 12, 2026